Espoo, Finland, 11 November 2020 – Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that it will present at the Nordic-American Life Science Investment and Partnering virtual conference on 12 November 2020.
Olli Keränen, CEO and Founder of Medtentia will present in the first session at 8.10am EST on the Emerging MedTech Day of the conference. His presentation is entitled: Medtentia, The Future of Mitral Valve Repair.
The Nordic-American Life Science Investment and Partnering conference connects global investors with Nordic life science advancements and provides insight into the Nordic companies breaking new ground in BioPharma and MedTech. The NALS Conference brings together dozens of high-caliber private and publicly-listed Nordic healthcare companies and other industry leaders in a three-day virtual event.